Literature DB >> 20409832

Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertension.

Masood Gilani1, Daniel R Kaiser, Christopher W Bratteli, Cheryl Alinder, Scott Rajala, Alan J Bank, Jay N Cohn.   

Abstract

Systemic inhibition of nitric oxide (NO) synthesis raises blood pressure, and endothelial dysfunction with reduced NO bioactivity is a precursor of atherosclerosis. Pre-hypertensive blood pressures place patients at increased risk for cardiovascular morbid events. Whether NO deficiency contributes to this increased risk has not been explored. Constitutive NO release was inhibited by infusion of the substituted arginine NG-nitro-L-arginine-methyl ester (L-NAME) in 10 normal volunteers. Hemodynamics, radial artery pulse contour analysis, brachial artery ultrasound, and aortic pulse wave velocity were monitored as well as plasma neurohormone levels. A modest rise in blood pressure within the normotensive range (113/65 to 124/77 mm Hg, P < .01) was accompanied by a rise in estimated systemic vascular resistance (1193 to 1514 dyne-sec-cm-5, P < .001). Pulse contour analysis revealed a fall to abnormal levels in systemic small artery elasticity (diastolic decay) (9.8 to 6.4 ml/mm Hg, P < .001) and a less consistent but significant increase in the second pressure peak in systole (P < .05). Large artery elasticity index, brachial artery caliber, and brachial artery compliance were unchanged. Flow-mediated brachial artery dilation was blunted slightly (5.29% to 4.47%, P = .06), and aortic pulse wave velocity increased slightly but significantly (8.25 to 8.98 m/s, P = .04), probably as a result of the rise in pressure. The magnitude of effect of L-NAME on small artery elasticity (-31.2% +/- 18.4%) was significantly greater and more consistent than its effect on other vascular measurements. Circulating neurohormonal vasoconstrictor levels fell or were unchanged after L-NAME, and a significant reduction in plasma norepinephrine was closely inversely correlated with the rise in blood pressure. Nitroglycerin infusion in 4 additional subjects produced selective relaxation in small arteries, whereas norepinephrine constricted both small and large arteries. A hemodynamic state consistent with pre-hypertension was induced by NO synthase inhibition in normal volunteers. Reduction in small artery compliance was a sensitive marker for this induced endothelial dysfunction and may serve as a useful marker for pre-hypertensive patients at risk for cardiovascular morbid events.

Entities:  

Year:  2007        PMID: 20409832     DOI: 10.1016/j.jash.2006.11.002

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  11 in total

1.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carmen A Peralta; David R Jacobs; Ronit Katz; Joachim H Ix; Magdalena Madero; Daniel A Duprez; Mark J Sarnak; Michael H Criqui; Holly J Kramer; Walter Palmas; David Herrington; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-10-14       Impact factor: 8.860

2.  Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study.

Authors:  Daniel A Duprez; Natalia Florea; Sue Duval; Catherine Koukol; Jay N Cohn
Journal:  J Hum Hypertens       Date:  2017-11-28       Impact factor: 3.012

3.  Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis.

Authors:  Daniel A Duprez; David R Jacobs; Pamela L Lutsey; David A Bluemke; Lyndia C Brumback; Joseph F Polak; Carmen A Peralta; Philip Greenland; Richard A Kronmal
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

4.  Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure.

Authors:  Luay Rifai; Carol Pisano; Janel Hayden; Suela Sulo; Marc A Silver
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

5.  Invited Commentary: Hypertension and Arterial Stiffness--Origins Remain a Dilemma.

Authors:  David R Jacobs; Daniel A Duprez; Daichi Shimbo
Journal:  Am J Epidemiol       Date:  2016-03-08       Impact factor: 4.897

Review 6.  Arterial stiffness as a risk factor for coronary atherosclerosis.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

7.  Untreated HIV infection and large and small artery elasticity.

Authors:  Jason V Baker; Daniel Duprez; Joshua Rapkin; Katherine Huppler Hullsiek; Harrison Quick; Richard Grimm; James D Neaton; Keith Henry
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

Review 8.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

Review 9.  Identifying early cardiovascular disease to target candidates for treatment.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

10.  Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Meyeon Park; Michael G Shlipak; Eric Vittinghoff; Ronit Katz; David Siscovick; Mark Sarnak; Joao A Lima; Chi-Yuan Hsu; Carmen A Peralta
Journal:  Clin Nephrol       Date:  2015-12       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.